Drug
Hrs 8427
Hrs 8427: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| HRS-8427 NCT06569056 | Phase 3 | Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) |
| HRS-8427 NCT06841731 | Phase 2 | Hospital-acquired Bacterial Pneumonia (HABP) |
Latest
No recent events.
Follow Hrs 8427 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.